Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health Inc reported an impressive 49.5% year-over-year revenue growth, attributed to a significantly higher member base, which reached 831,000 by the end of 3Q25, exceeding previous estimates. Gross margins also benefited from a more efficient care team and an improved program mix, expanding to 68.2%, surpassing expectations. The company's strong performance and strategic positioning in the cardiometabolic health sector are expected to propel growth rates exceeding 50% in FY25 while simultaneously enhancing EBITDA margins into positive territory.

Bears say

The analysis reveals a negative outlook for Omada Health's stock, primarily due to concerns regarding a potentially short-lived GLP-1-driven growth cycle, which is projected to result in a slowdown to approximately 20% growth. Additionally, the ramp in adjusted EBITDA is expected to decelerate post-2025 as the company invests in its new GLP-1 care track, raising doubts about the sustainability of high margins in the long term. Furthermore, increased competition and price reductions in the GLP-1 space could diminish profitability, necessitating enhanced management solutions for delivery optimization to address rising demand for weight loss offerings.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.